is there a tirzepatide shortage off the list What Tirzepatide Used for? Approved and Potential Uses Weight-loss drugs could see a
Description
and (ii) by promoting lipid storage in adipose tissue in the periphery

Concerns about lean mass loss and metabolism Clinical data shows semaglutide can reduce lean body mass, with losses ranging from nearly 0% to 40% of total weight reduction

Warning signs include muscle weakness or cramps, palpitations, persistent fatigue, severe vomiting or diarrhoea, and paraesthesia

Experimental and clinical data indicate that GLP-1RAs reduce circulating pro-inflammatory cytokines, improve endothelial function, and favour macrophage polarization toward an anti-inflammatory M2 phenotype, thereby attenuating adipose tissue inflammation
Diabetes Spectrum : A Publication of the American Diabetes Association, 30 (3), 153-156

Centers For Disease Control and Prevention (CDC)
